The treatment is one of a number of new products that the company expects to bring in a combined $20 billion in potential annual revenue by 2030.
Pfizer said Friday that the Food and Drug Administration had approved its new ulcerative colitis pill etrasimod, which the company will market under the name Velsipity.
The FDA approved Velsipity to treat “moderately to severely active ulcerative colitis in adults,” it said. Ulcerative colitis is a chronic condition that can cause chronic diarrhea, among other symptoms. Pfizer said in a presentation last year that it projects global revenue from Velsipity in ulcerative colitis to peak at between $1 billion and $2 billion. It is one of a number of new products that the company expects to bring a combined $20 billion in potential annual revenue by 2030.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
FDA approves Pfizer’s Braftovi plus Mektovi for a type of non-small cell lung cancerCiara Linnane is MarketWatch's investing- and corporate-news editor. She is based in New York.
Leer más »
South El Camino Real apartment complex project wins Encinitas approvalPlanning commissioners recommend City Council adjust area’s vehicle and bike lanes to reduce automotive speeds, improve cyclists’ safety
Leer más »
FDA Warns of Dangers of Compounded Ketamine for Psychiatric UseThe U.S. Food and Drug Administration is warning consumers about risks of using compounded versions of the drug ketamine, often taken for psychiatric disorders.
Leer más »
Hata receives in-principle approval to be fifth Malaysian digital exchangeThe Hata digital asset exchange has received in-principle regulatory approval to launch digital asset exchange and broker services in Malaysia.
Leer más »
Many arthritis and pain meds are tainted with harmful drugs, FDA warnsThis Week's Health Headlines: Bionic woman, Sex life hacks, & Deadly “superbug”
Leer más »
Family Dollar recalling OTC drugs and 'medical device products' from multiple brands, FDA saysThe recall impacts stores in 23 states. The list of items recalled includes products ranging from cold medicines to toothpaste, pregnancy tests, shampoo, and more.
Leer más »